Pharma and Healthcare Consulting Leader, PwC China
Dr. Jia Xu, the lead consulting partner of the pharma and healthcare sectors at PwC China, has nearly 20 years of combined professional consulting and industry experience. Dr. Xu joined the firm in May 2008 after working for eight years at a global healthcare leading company in Singapore.
She has a wealth of experience in the pharmaceutical business: in the operational, quality, technical and business aspects, and has a deep understanding of compliance, operations, supply chain and risk management. After joining PwC China, Dr. Xu worked with organisations to develop their China growth strategy. She also led commercial due diligence and post-merger integration in a number of major pharma M&A, advised clients on growth and capability assessment, execution of performance improvement, and compliance risk mitigation.
Dr. Xu has a PhD in Organic Chemistry from the National University of Singapore. She was elected to the executive board of the ISPE Singapore Affiliate in 2008. She is also a board member of ISPE China. In 2010, Dr. Xu was granted the Top Calibre Overseas Talent award by Beijing’s Chaoyang district government.
Relevant project experience
© 2003 - 2020 PwC. All rights reserved. PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.